Kabra Drugs
30.90
+0.98(+3.28%)
Market Cap₹73.22 Cr
PE Ratio59.84
IndustryHealthcare
Company Performance:
1D+3.28%
1M+4.15%
6M+55.35%
1Y+192.61%
5Y+611.98%
View Company Insightsright
More news about Kabra Drugs
06Aug 25
Kabra Drugs Limited Diversifies into Medical Equipment, Establishes Chennai Office
Kabra Drugs Limited's Board of Directors has approved diversification into the medical equipment and medical instruments sector. The company will establish a new office in Chennai at Cactus Corporate Coworking, Tecci Park, to support this venture. The decision was made during a board meeting on August 6, 2025, from 6:00 PM to 7:00 PM (IST). This move represents a significant expansion of Kabra Drugs' business operations beyond pharmaceuticals.
 no imag found
Kabra Drugs
30.90
+0.98
(+3.28%)
1 Year Returns:+192.61%
Industry Peers
Sun Pharmaceutical
1,695.10
(-0.44%)
Divis Laboratories
6,024.50
(-1.91%)
Torrent Pharmaceuticals
3,939.00
(-0.94%)
Cipla
1,330.00
(-0.25%)
Dr Reddys Laboratories
1,241.20
(-0.30%)
Lupin
2,173.70
(-2.02%)
Zydus Life Science
888.15
(-1.86%)
Mankind Pharma
2,060.20
(-0.97%)
Aurobindo Pharma
1,191.00
(+0.80%)
Alkem Laboratories
5,684.00
(+0.38%)